Concentrating on chromatin-mediated epigenetic regulation has emerged as a possible avenue for creating novel therapeutics for a variety of central nervous technique Conditions, including cognitive Ailments and melancholy. Histone deacetylase (HDAC) inhibitors have already been pursued as cognitive